Texas

The Health and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) is accepting comments until March 10th on the March 2022 draft Specialty Drug List. Stakeholders should send submissions on the Specialty Drug Submission Spreadsheet. 

 Also in Texas, the HHSC adopted a final rule establishing a process for Medicaid Managed Care organizations (MCOs) to recoup certain overpayments made to health care providers in connection with missing electronic visit verification information. The rule also requires MCOs to give providers at least 60 days to correct a deficiency.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-25T11:27:54-05:00February 25, 2022|Texas|

Utah

The Board of Pharmacy published its February 2022 newsletter. Highlights include the impact of HB 178 on pharmacy practice, pharmacy staff supervision, insulin refills, Controlled Substance Database (CDS) updates when returning controlled substances to stock, CDS and the DSP12 Transmission Form of Rx Origin Code and SafeUT Frontline app.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-02-25T11:25:07-05:00February 25, 2022|Utah|

Virginia

The Legislature’s crossover deadline for bills to pass one chamber to be eligible for further consideration was met on February 15. The following bills of interest to pharmacy met the deadline: 

  • HB 1323 and SB 672 – both bills expand pharmacy personnel immunization and testing authority to mirror the PREP (Public Readiness and Emergency Preparedness) Act; SB 672 also expands the state’s current allowances on conditions pharmacists may test and/or treat. NACDS has been actively supporting both bills, which are headed for consideration in conference committee 
  • HB 1324 – this bill requires the Board of Pharmacy to adopt regulations for work environment requirements for pharmacy personnel by September 1, 2022. The regulations must include addressing pharmacy staffing and breaks; state standards that ensure adequate time to complete professional duties; and limit productivity or production quotas to the extent that such factors interfere with the ability to provide appropriate professional services to the public. The bill was amended to remove language that would have allowed it to be promulgated as an emergency measure, thus ensuring stakeholders’ ability to participate in the regulatory process 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-02-25T11:24:32-05:00February 25, 2022|Virginia|

Washington

Gov. Jay Inslee (D) issued a proclamation removing the statewide indoor mask mandate effective February 18, 2022.

Also in Washington, legislation twice amended that NACDS opposed that mandates prescription label translations, unanimously passed the House earlier this month. This week it was approved by the Senate Health and Long-Term Care and Rules Committees, and now goes to the full Senate for review. (ESHB 1852) 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-25T11:23:54-05:00February 25, 2022|Washington|

Alabama

The Alabama Medicaid Agency will host a virtual online seminar to provide an update to the cost-effectiveness methodology to Alabama Coordinated Health Network (ACHN) provider groups. The purpose of the online seminar is to provide an overview and answer questions on the modified cost effectiveness methodology that will take effect on April 15, 2022, check write.  

Also in Alabama, the Board of Pharmacy has issued a proposed rule regarding non-disciplinary penalties for late renewal of license, permit, registration, certification, or any similar document issued.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-02-18T09:49:02-05:00February 18, 2022|Alabama|

Arkansas

The Legislature convened its biennial fiscal session on February 14th.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-18T09:51:20-05:00February 18, 2022|Arkansas|

California

The following alerts have been recently posted to the Medi-Cal Rx Web Portal:  

Also in California, the Department of Health Care Services posted this article to the Medi-Cal Rx Web Portal: Professional Organizations Push for Recall of Buprenorphine Dental Warning.  

Also, in California, COVID-19 related news highlighted below: 

Finally in California, the Board of Pharmacy released Notices of Modified Text for the following and will accept written comments on the proposed modifications until March 2, 2022. 

  • Self-Assessment of a Wholesaler/Third-Party Logistics Provider by the Designated Representative-In-Charge or Responsible Manager 
  • Self-Assessment of a Pharmacy by the Pharmacist-in-Charge 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-02-18T09:48:18-05:00February 18, 2022|California|

Florida

Revised PML Tip Sheet, beginning March 1, 2022, an enhancement will be applied to the NPI Mapping Logic which will affect providers and health plans who submit claims and/or encounters to Florida Medicaid. An updated Provider Master List tip sheet is now available on the Managed Care Support section of the Florida Medicaid public Web Portal that details the changes. Health plans are encouraged to review the tip sheet to understand how the enhancement will affect their encounter submissions. Health plans can stay connected by visiting the Florida Medicaid public Web Portal often for the most up-to-date information on these changes. For additional assistance, please contact the Health Plan Support team by emailing healthplan.support@gainwelltechnologies.com.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-02-18T09:45:37-05:00February 18, 2022|Florida|
Go to Top